Lexicon Pharmaceuticals
LXRX
#6532
Rank
ยฃ0.57 B
Marketcap
ยฃ1.35
Share price
-0.54%
Change (1 day)
215.28%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): -ยฃ0.15

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ0.14. In 2024 the company made an earnings per share (EPS) of -ยฃ0.47 an increase over its 2023 EPS that were of -ยฃ0.59.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ0.15-68.67%
2024-ยฃ0.47-20%
2023-ยฃ0.5931.15%
2022-ยฃ0.45-0%
2021-ยฃ0.4510.91%
2020-ยฃ0.41-145.08%
2019ยฃ0.90-206.09%
2018-ยฃ0.85-5.74%
2017-ยฃ0.90-10.95%
2016-ยฃ1.012640%
2015-ยฃ0.03699-96.34%
2014-ยฃ1.01-2.53%
2013-ยฃ1.04-9.09%
2012-ยฃ1.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
ยฃ13.15-9,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ4.05-2,984.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ31.90-22,794.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-ยฃ4.32 2,973.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ4.66-3,415.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-ยฃ0.37 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-ยฃ0.55 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ1.35-1,057.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-ยฃ56.75 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA